Verzenio Side Effects: What Patients Are Reporting

Verzenio Side Effects: What Patients Are Reporting

Matthew Goetz, MD, talks about patient-reported Verzenio side effects and how to manage diarrhea caused by Verzenio.
Dec 11, 2018
/_next/static/media/art.743baba8.png
00:00
Download
00:00

Dr. Matthew Goetz discusses the research he presented at the 2018 San Antonio Breast Cancer Symposium on patient-reported outcomes from women being treated with Verzenio (chemical name: abemaciclib) plus an aromatase inhibitor as the first treatment for advanced-stage, hormone-receptor-positive, HER2-negative breast cancer.

Listen to the podcast to hear Dr. Goetz talk about:

  • what patient-reported outcomes are and why they're important for both doctors and patients

  • the Verzenio side effects reported in the study

  • how diarrhea caused by Verzenio can be proactively managed so a woman doesn't have to plan her life around a side effect

About the guest
 
Matthew Goetz headshot
Matthew Goetz, MD

Dr. Matthew Goetz is a professor of oncology at the Mayo Clinic where he is also co-leader of the Women's Cancer Program and chair of the Breast Cancer Disease-Oriented Group.

— Last updated on June 29, 2022, 2:58 PM

 
Lilly

This content made possible by Lilly Oncology.

 
 
Support Breastcancer.org to produce more content like this

Your donation goes directly to what you read, hear, and see on Breastcancer.org.

Donate